Website Badges (3).png
Sonic Incytes
Liver health insights you can count on
INVESTMENt

November, 2021

Sector

Med-Tech

FUND

Fund II

location

Vancouver, British Columbia

co-investors

Gaingels
Nicola Venture Capital
Nimbus Synergies
Quimby Investments
Pacific Hi-Tech
Sunhope Venture Capital

Image-empty-state_edited.jpg

Barry Allen

CEO

Quintuple aim
Alertive.png

Sonic Incytes has developed a breakthrough, point of care ultrasound solution for fast and accurate assessing and managing of chronic liver disease—an emerging global health epidemic, affecting one in four persons worldwide. Sonic Incytes' portable, handheld solution uses technology similar to MRI elastography, quantifying liver disease using 3D tissue sampling. Sonic Incytes provides a clear picture of the liver and the entire procedure takes about five minutes in a doctor’s office. They are redefining the standard of care in quantifying fatty liver disease.

WM360_logo-18.png